Alzheimer’s drug donanemab gets FDA advisory committee’s green light : Shots
An advisory committee to the Food and Drug Administration has recommended that the federal agency approve Alzheimer’s drug donanemab. Andrew Harnik/AP hide caption toggle caption Andrew Harnik/AP Advisors to the…